BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Allergy Therapeutics plc: Trading Update And Notice Of Results


1/14/2014 9:11:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

14 January 2014 -- Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in aluminium free allergy vaccines, will announce its unaudited interim results for the period ended 31 December 2013 on 24 March 2014.

The Company is pleased to report that it expects first half revenues before milestones and rebates of approximately £29.9m (H1 2013: £26.6m), an improvement of 12%. This double digit sales growth has been driven by the Company’s improving trading performance as it continues to increase its market share in all of its main markets and supported by a foreign exchange benefit of £1.6m.

For further information

Allergy Therapeutics +44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite, Finance Director
Peel Hunt LLP +44 (0) 20 7418 8900
James Steel
Oliver Jackson
FTI Consulting +44 (0) 207 831 3113
Simon Conway
Victoria Foster Mitchell

About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving sales in the prior financial year of £39.3 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging Markets.
Allergy Therapeutics vaccines are aluminium free, containing instead tyrosine as a depot, Tyrosine is a natural product that is readily metabolised and eliminated from the body.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES